Study details
Enrolling now
Anticoagulation Trial to Prevent Stroke After Surgery
Population Health Research Institute
NCT IDNCT03968393ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
2,270
Study length
about 9.6 years
Ages
55+
Locations
2 sites in CA, TX
What this study is about
Researchers are testing whether a medication can prevent strokes in people who have had atrial fibrillation (AFib) after surgery. The trial will last for 3 years and involve about 2270 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Non-vitamin K oral anticoagulant (NOAC)
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
Blood Products/Modifiers/Volume Expanders (Unknown Cellular or Molecular Interaction)
Drug routes
oral (Oral Tablet)
Endpoints
Secondary: Incidence of all-cause mortality
Body systems
Neurology, Cardiology / Heart